Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

The Relation Between Red Blood Cell Distribution Width and Coronary Atherosclerotic Plaque Vulnerability Detected by Intracoronary Optical Coherence Tomography

Author(s): Peng Jin, Si-Jing Wu, Qian Ma, Wei Liu, Ying-Xin Zhao, Hong-Ya Han, Fang-Jie Hou, Ya Li and Yu-Jie Zhou*

Volume 20, Issue 6, 2022

Published on: 01 August, 2022

Page: [501 - 507] Pages: 7

DOI: 10.2174/1570161120666220527093551

Price: $65

Abstract

Background: A higher red blood cell distribution width (RDW) predicts major adverse cardiac events in patients with coronary artery disease (CAD). However, there are only a few studies regarding the relationship between RDW and vulnerable plaques. Thus, the purpose of the present study is to retrospectively explore the predictive value of the association between RDW and plaque vulnerability assessed by optical coherence tomography (OCT) in patients with cardiovascular (CV) diseases.

Methods: This study included 35 patients with stable angina pectoris (SAP) and 70 patients with the acute coronary syndrome (ACS). We documented clinical features as well as peripheral RDW. Plaque vulnerability was determined by OCT. We defined thin-cap fibroatheroma (TCFA) as a lipid-rich plaque (fibrous cap <65 μm thick).

Results: Plaque rupture was detected more frequently in patients with ACS compared with patients with SAP (62.9 vs. 2.9%, p<0.001, and the corresponding TCFA were 50.69±15.68 vs. 80.03±21.60 μm, p<0.001, respectively). A higher RDW was found in patients with ACS than in patients with SAP (p<0.001). A cut-off value of RDW >13.85% could detect ruptured plaque with a sensitivity of 72.3% and a specificity of 62%.

Conclusion: TCFA and plaque rupture were detected more frequently in patients with ACS compared with SAP. Elevated RDW was positively the predictive value of the association between plaque vulnerability.

Keywords: Red blood cell distribution width, coronary artery disease, plaque vulnerability, optical coherence tomography, acute coronary syndrome, thin-cap fibroatheroma.

« Previous Next »
Graphical Abstract

[1]
Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: Ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007; 50(10): 933-9.
[http://dx.doi.org/10.1016/j.jacc.2007.04.082] [PMID: 17765119]
[2]
Kramer MC, Rittersma SZ, de Winter RJ, et al. Relationship of thrombus healing to underlying plaque morphology in sudden coronary death. J Am Coll Cardiol 2010; 55(2): 122-32.
[http://dx.doi.org/10.1016/j.jacc.2009.09.007] [PMID: 19818571]
[3]
Shah PK. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 2003; 41(4) (Suppl. S): 15S-22S.
[http://dx.doi.org/10.1016/S0735-1097(02)02834-6] [PMID: 12644336]
[4]
Oncel RC, Ucar M, Karakas MS, et al. Relation of neutrophil-to-lymphocyte ratio with GRACE risk score to in-hospital cardiac events in patients with ST-segment elevated myocardial infarction. Clin Appl Thromb Hemost 2015; 21(4): 383-8.
[http://dx.doi.org/10.1177/1076029613505763] [PMID: 24078555]
[5]
Montagnana M, Cervellin G, Meschi T, Lippi G. The role of red blood cell distribution width in cardiovascular and thrombotic disorders. Clin Chem Lab Med 2011; 50(4): 635-41.
[PMID: 22505527]
[6]
Goyal H, Gupta S, Singla U. Level of red cell distribution width is affected by various factors. Clin Chem Lab Med 2016; 54(12)e387
[http://dx.doi.org/10.1515/cclm-2016-0195] [PMID: 27166724]
[7]
Prati F, Regar E, Mintz GS, et al. Expert review document on methodology, terminology, and clinical applications of optical coherence tomog-raphy: Physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclero-sis. Eur Heart J 2010; 31(4): 401-15.
[http://dx.doi.org/10.1093/eurheartj/ehp433] [PMID: 19892716]
[8]
Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial plaque by optical coherence tomography. Am J Cardiol 2006; 97(8): 1172-5.
[http://dx.doi.org/10.1016/j.amjcard.2005.11.035] [PMID: 16616021]
[9]
Di Vito L, Yoon JH, Kato K, et al. Comprehensive overview of definitions for optical coherence tomography-based plaque and stent anal-yses. Coron Artery Dis 2014; 25(2): 172-85.
[http://dx.doi.org/10.1097/MCA.0000000000000072] [PMID: 24356250]
[10]
Räber L, Mintz GS, Koskinas KC, et al. ESC Scientific Document Group. Clinical use of intracoronary imaging. Part 1: Guidance and optimi-zation of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J 2018; 39(35): 3281-300.
[http://dx.doi.org/10.1093/eurheartj/ehy285] [PMID: 29790954]
[11]
Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010; 30(7): 1282-92.
[http://dx.doi.org/10.1161/ATVBAHA.108.179739] [PMID: 20554950]
[12]
Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342(12): 836-43.
[http://dx.doi.org/10.1056/NEJM200003233421202] [PMID: 10733371]
[13]
Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336(18): 1276-82.
[http://dx.doi.org/10.1056/NEJM199705013361802] [PMID: 9113930]
[14]
Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: A comprehensive morphological classifica-tion scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20(5): 1262-75.
[http://dx.doi.org/10.1161/01.ATV.20.5.1262] [PMID: 10807742]
[15]
Raffel OC, Tearney GJ, Gauthier DD, Halpern EF, Bouma BE, Jang IK. Relationship between a systemic inflammatory marker, plaque in-flammation, and plaque characteristics determined by intravascular optical coherence tomography. Arterioscler Thromb Vasc Biol 2007; 27(8): 1820-7.
[http://dx.doi.org/10.1161/ATVBAHA.107.145987] [PMID: 17541021]
[16]
Grube E, Gerckens U, Buellesfeld L, Fitzgerald PJ. Intracoronary imaging with optical coherence tomography: A new high-resolution tech-nique providing striking visulaization in the coronary artery. Circulation 2002; 106(18): 2409-10.
[http://dx.doi.org/10.1161/01.CIR.0000037784.22657.6E] [PMID: 12403675]
[17]
Tearney GJ, Jang IK, Kang DH, et al. Porcine coronary imaging in vivo by optical coherence tomography. Acta Cardiol 2000; 55(4): 233-7.
[http://dx.doi.org/10.2143/AC.55.4.2005745] [PMID: 11041121]
[18]
Narula J, Garg P, Achenbach S, Motoyama S, Virmani R, Strauss HW. Arithmetic of vulnerable plaques for noninvasive imaging. Nat Clin Pract Cardiovasc Med 2008; 5(S2) (Suppl. 2): S2-S10.
[http://dx.doi.org/10.1038/ncpcardio1247] [PMID: 18641603]
[19]
Brezinski ME, Tearney GJ, Bouma BE, et al. Optical coherence tomography for optical biopsy. Properties and demonstration of vascular pathology. Circulation 1996; 93(6): 1206-13.
[http://dx.doi.org/10.1161/01.CIR.93.6.1206] [PMID: 8653843]
[20]
Cilingiroglu M, Oh JH, Sugunan B, et al. Detection of vulnerable plaque in a murine model of atherosclerosis with optical coherence tomog-raphy. Catheter Cardiovasc Interv 2006; 67(6): 915-23.
[http://dx.doi.org/10.1002/ccd.20717] [PMID: 16602128]
[21]
Jang IK, Tearney GJ, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005; 111(12): 1551-5.
[http://dx.doi.org/10.1161/01.CIR.0000159354.43778.69] [PMID: 15781733]
[22]
Barlis P, Serruys PW, Gonzalo N, van der Giessen WJ, de Jaegere PJ, Regar E. Assessment of culprit and remote coronary narrowings using optical coherence tomography with long-term outcomes. Am J Cardiol 2008; 102(4): 391-5.
[http://dx.doi.org/10.1016/j.amjcard.2008.03.071] [PMID: 18678293]
[23]
Kato K, Yonetsu T, Kim SJ, et al. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: A 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging 2012; 5(4): 433-40.
[http://dx.doi.org/10.1161/CIRCIMAGING.112.973701] [PMID: 22679059]
[24]
Tazaki R, Tanigawa J, Fujisaka T, et al. Plasma PTX3 level was associated with plaque vulnerability assessed by OCT in patients with CAD. Int Heart J 2016; 57: 18-24.
[http://dx.doi.org/10.1536/ihj.15-248] [PMID: 26673442]
[25]
Akin F, Köse N, Ayça B, et al. Relation between red cell distribution width and severity of coronary artery disease in patients with acute my-ocardial infarction. Angiology 2013; 64(8): 592-6.
[http://dx.doi.org/10.1177/0003319712461931] [PMID: 23070683]
[26]
Shah N, Pahuja M, Pant S, et al. Red cell distribution width and risk of cardiovascular mortality: Insights from National Health and Nutrition Examination Survey (NHANES)-III. Int J Cardiol 2017; 232: 105-10.
[http://dx.doi.org/10.1016/j.ijcard.2017.01.045] [PMID: 28117138]
[27]
Kinlay S, Schwartz GG, Olsson AG, et al. Myocardial ischemia reduction with aggressive cholesterol lowering study investigators. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation 2003; 108(13): 1560-6.
[http://dx.doi.org/10.1161/01.CIR.0000091404.09558.AF] [PMID: 12975259]
[28]
Kucera M, Balaz D, Kruzliak P, et al. The effects of atorvastatin treatment on the mean platelet volume and red cell distribution width in pa-tients with dyslipoproteinemia and comparison with plasma atherogenicity indicators--A pilot study. Clin Biochem 2015; 48(9): 557-61.
[http://dx.doi.org/10.1016/j.clinbiochem.2015.02.010] [PMID: 25727667]
[29]
Zalawadiya SK, Zmily H, Farah J, Daifallah S, Ali O, Ghali JK. Red cell distribution width and mortality in predominantly African-American population with decompensated heart failure. J Card Fail 2011; 17(4): 292-8.
[http://dx.doi.org/10.1016/j.cardfail.2010.11.006] [PMID: 21440866]
[30]
Burnett H, Earley A, Voors AA, et al. Thirty years of evidence on the efficacy of drug treatments for chronic heart failure with reduced ejec-tion fraction: A network meta-analysis. Circ Heart Fail 2017; 10(1)e003529
[http://dx.doi.org/10.1161/CIRCHEARTFAILURE.116.003529] [PMID: 28087688]
[31]
Tomaniak M, Kołtowski Ł, Jonik S, et al. Platelet to red cell distribution width ratio for predicting clopidogrel efficacy in patients undergoing percutaneous coronary interventions: Insights from the ONSIDE-TEST study. Pol Arch Intern Med 2019; 129(2): 117-22.
[http://dx.doi.org/10.20452/pamw.4441] [PMID: 30758314]

Rights & Permissions Print Cite
Article Metrics
4
© 2024 Bentham Science Publishers | Privacy Policy